Treatment of insulin resistant diabetes with thalidomine

Details Treatment of insulin resistant diabetes with thalidomine Treatment of insulin resistant diabetes with thalidomine

1993-12-23

1995-04-11

Henley, III, Raymond

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

514866, A61K 31445

Patent

active

054058554

ABSTRACT:
A method for treating insulin-resistant diabetes in mammals which comprises administering to said afflicted animals a prophylactically or therapeutically effective amount of thalidomide.

REFERENCES:
patent: 5104899 (1992-04-01), Young et al.

Affiliated with

Also associated with

Rating

Treatment of insulin resistant diabetes with thalidomine does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Treatment of insulin resistant diabetes with thalidomine, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of insulin resistant diabetes with thalidomine will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1538737